Annual SGA
$8.73 M
+$1.29 M+17.32%
December 31, 2022
Summary
- As of February 10, 2025, DFFN annual SGA is $8.73 million, with the most recent change of +$1.29 million (+17.32%) on December 31, 2022.
- During the last 3 years, DFFN annual SGA has risen by +$3.90 million (+80.69%).
Performance
DFFN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly SGA
$2.22 M
-$737.30 K-24.93%
June 30, 2023
Summary
- As of February 10, 2025, DFFN quarterly SGA is $2.22 million, with the most recent change of -$737.30 thousand (-24.93%) on June 30, 2023.
- Over the past year, DFFN quarterly SGA has increased by +$83.10 thousand (+3.89%).
Performance
DFFN Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
-$588.61 M
-$13.08 M-2.27%
June 30, 2023
Summary
- As of February 10, 2025, DFFN TTM SGA is -$588.61 million, with the most recent change of -$13.08 million (-2.27%) on June 30, 2023.
- Over the past year, DFFN TTM SGA has dropped by -$596.74 million (-7339.15%).
Performance
DFFN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
DFFN Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.3% | +3.9% | -7339.1% |
| 3 y3 years | +80.7% | +52.3% | -10000.0% |
| 5 y5 years | +41.1% | +33.7% | -10000.0% |
DFFN Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -14.8% | -24.9% | -12.9% | +22.3% | at low |
| 5 y | 5-year | at high | -44.7% | -24.9% | -42.6% | +69.4% | at low |
| alltime | all time | -21.3% | -99.5% | -53.1% | -145.1% | +4519.5% | at low |
Diffusion Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $2.22 M(-24.9%) | $9.65 M(+0.9%) |
| Mar 2023 | - | $2.96 M(+26.2%) | $9.56 M(+9.5%) |
| Dec 2022 | $8.73 M(+17.3%) | $2.34 M(+10.3%) | $8.74 M(+4.9%) |
| Sep 2022 | - | $2.12 M(-0.6%) | $8.33 M(+2.4%) |
| Jun 2022 | - | $2.14 M(+0.4%) | $8.13 M(+3.8%) |
| Mar 2022 | - | $2.13 M(+10.0%) | $7.83 M(+5.2%) |
| Dec 2021 | $7.45 M(+15.5%) | $1.93 M(+0.2%) | $7.45 M(+6.5%) |
| Sep 2021 | - | $1.93 M(+5.1%) | $6.99 M(-2.5%) |
| Jun 2021 | - | $1.84 M(+5.4%) | $7.17 M(+5.6%) |
| Mar 2021 | - | $1.74 M(+17.8%) | $6.79 M(+5.4%) |
| Dec 2020 | $6.44 M(+33.3%) | $1.48 M(-30.0%) | $6.44 M(+3.3%) |
| Sep 2020 | - | $2.11 M(+44.9%) | $6.24 M(+15.2%) |
| Jun 2020 | - | $1.46 M(+4.6%) | $5.42 M(+7.8%) |
| Mar 2020 | - | $1.39 M(+9.3%) | $5.03 M(+4.0%) |
| Dec 2019 | $4.83 M(-21.6%) | $1.27 M(-1.2%) | $4.83 M(-2.9%) |
| Sep 2019 | - | $1.29 M(+20.8%) | $4.98 M(-5.7%) |
| Jun 2019 | - | $1.07 M(-11.0%) | $5.28 M(-10.1%) |
| Mar 2019 | - | $1.20 M(-15.4%) | $5.87 M(-4.8%) |
| Dec 2018 | $6.17 M(-0.4%) | $1.42 M(-10.7%) | $6.17 M(+2.2%) |
| Sep 2018 | - | $1.59 M(-4.3%) | $6.03 M(+0.5%) |
| Jun 2018 | - | $1.66 M(+10.9%) | $6.00 M(-2.2%) |
| Mar 2018 | - | $1.50 M(+16.7%) | $6.14 M(-0.9%) |
| Dec 2017 | $6.19 M(-44.2%) | $1.28 M(-17.7%) | $6.19 M(+4.4%) |
| Sep 2017 | - | $1.56 M(-13.2%) | $5.93 M(-27.9%) |
| Jun 2017 | - | $1.80 M(+15.6%) | $8.22 M(-6.3%) |
| Mar 2017 | - | $1.55 M(+51.8%) | $8.78 M(-20.8%) |
| Dec 2016 | $11.09 M(+339.8%) | $1.02 M(-73.4%) | $11.09 M(-2.4%) |
| Sep 2016 | - | $3.85 M(+64.0%) | $11.36 M(+43.3%) |
| Jun 2016 | - | $2.35 M(-39.2%) | $7.93 M(+33.8%) |
| Mar 2016 | - | $3.86 M(+198.4%) | $5.93 M(+134.9%) |
| Dec 2015 | $2.52 M(-47.0%) | $1.29 M(+206.8%) | $2.52 M(+33.0%) |
| Sep 2015 | - | $422.00 K(+21.6%) | $1.90 M(-43.3%) |
| Jun 2015 | - | $347.10 K(-24.3%) | $3.34 M(-20.5%) |
| Mar 2015 | - | $458.80 K(-31.4%) | $4.21 M(-11.6%) |
| Dec 2014 | $4.76 M | $668.60 K(-64.2%) | $4.76 M(-46.1%) |
| Sep 2014 | - | $1.87 M(+54.4%) | $8.83 M(+10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | $1.21 M(+19.8%) | $7.98 M(+5.4%) |
| Mar 2014 | - | $1.01 M(-78.6%) | $7.57 M(+3.3%) |
| Dec 2013 | $7.33 M(+9.4%) | $4.73 M(+361.8%) | $7.33 M(+111.0%) |
| Sep 2013 | - | $1.03 M(+27.4%) | $3.48 M(-11.7%) |
| Jun 2013 | - | $804.60 K(+4.8%) | $3.93 M(-27.6%) |
| Mar 2013 | - | $767.80 K(-12.5%) | $5.43 M(-18.9%) |
| Dec 2012 | $6.70 M(-33.0%) | $877.60 K(-40.9%) | $6.70 M(-16.3%) |
| Sep 2012 | - | $1.48 M(-35.6%) | $8.01 M(-24.7%) |
| Jun 2012 | - | $2.30 M(+13.3%) | $10.64 M(+2.5%) |
| Mar 2012 | - | $2.03 M(-7.0%) | $10.38 M(+9.2%) |
| Dec 2011 | $10.01 M(+47.8%) | $2.19 M(-46.9%) | $9.50 M(+0.4%) |
| Sep 2011 | - | $4.11 M(+101.4%) | $9.46 M(+35.6%) |
| Jun 2011 | - | $2.04 M(+76.2%) | $6.98 M(+3.5%) |
| Mar 2011 | - | $1.16 M(-45.9%) | $6.74 M(-0.4%) |
| Dec 2010 | $6.77 M(+133.2%) | $2.14 M(+31.5%) | $6.77 M(+15.1%) |
| Sep 2010 | - | $1.63 M(-9.8%) | $5.88 M(+22.4%) |
| Jun 2010 | - | $1.81 M(+52.7%) | $4.81 M(+40.9%) |
| Mar 2010 | - | $1.18 M(-5.8%) | $3.41 M(+37.3%) |
| Dec 2009 | $2.90 M(+205.1%) | $1.26 M(+126.1%) | $2.48 M(+74.6%) |
| Sep 2009 | - | $556.00 K(+34.3%) | $1.42 M(+24.6%) |
| Jun 2009 | - | $414.00 K(+60.6%) | $1.14 M(+20.5%) |
| Mar 2009 | - | $257.80 K(+31.7%) | $947.90 K(-0.3%) |
| Dec 2008 | $950.80 K(+1603.9%) | $195.70 K(-28.7%) | $950.80 K(-486.7%) |
| Sep 2008 | - | $274.50 K(+24.8%) | -$245.90 K(-7.4%) |
| Jun 2008 | - | $219.90 K(-15.7%) | -$265.60 K(+138.6%) |
| Mar 2008 | - | $260.70 K(-126.0%) | -$111.30 K(-299.5%) |
| Dec 2007 | $55.80 K(+33.2%) | -$1.00 M(-492.9%) | $55.80 K(-94.9%) |
| Sep 2007 | - | $254.80 K(-31.9%) | $1.09 M(+30.0%) |
| Jun 2007 | - | $374.20 K(-12.5%) | $836.70 K(+65.0%) |
| Mar 2007 | - | $427.80 K(+1275.6%) | $507.20 K(+511.1%) |
| Dec 2006 | $41.90 K(-54.6%) | $31.10 K(+763.9%) | $83.00 K(+59.9%) |
| Sep 2006 | - | $3600.00(-91.9%) | $51.90 K(+7.5%) |
| Jun 2006 | - | $44.70 K(+1141.7%) | $48.30 K(+1241.7%) |
| Mar 2006 | - | $3600.00 | $3600.00 |
| Dec 2005 | $92.20 K(-98.6%) | - | - |
| Dec 1999 | $6.42 M(+100.6%) | - | - |
| Dec 1998 | $3.20 M | - | - |
FAQ
- What is Diffusion Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals annual SGA year-on-year change?
- What is Diffusion Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals quarterly SGA year-on-year change?
- What is Diffusion Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals TTM SGA year-on-year change?
What is Diffusion Pharmaceuticals annual SGA?
The current annual SGA of DFFN is $8.73 M
What is the all time high annual SGA for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high annual SGA is $11.09 M
What is Diffusion Pharmaceuticals annual SGA year-on-year change?
Over the past year, DFFN annual SGA has changed by +$1.29 M (+17.32%)
What is Diffusion Pharmaceuticals quarterly SGA?
The current quarterly SGA of DFFN is $2.22 M
What is the all time high quarterly SGA for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high quarterly SGA is $4.73 M
What is Diffusion Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, DFFN quarterly SGA has changed by +$83.10 K (+3.89%)
What is Diffusion Pharmaceuticals TTM SGA?
The current TTM SGA of DFFN is -$588.61 M
What is the all time high TTM SGA for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high TTM SGA is -$12.74 M
What is Diffusion Pharmaceuticals TTM SGA year-on-year change?
Over the past year, DFFN TTM SGA has changed by -$596.74 M (-7339.15%)